Josep Mallolas Masferrer

Professor of Medicina

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Josep Mallolas Masferrer is a Professor of Medicina at the University of Barcelona, Spain. His research areas encompass HIV treatment outcomes, sexually transmitted infections, and the epidemiological changes affecting individuals living with HIV. Recent publications include studies on the effectiveness and safety of various HIV treatments, as well as investigations into sexually transmitted infections, highlighting his focus on clinical practice and patient care.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Alexy Inciarte

Associated profesor

University of Barcelona

SPAIN

View details

FREDERIC GOMEZ

Associate Professor

SPAIN

View details

Yuliya Poliakova Mazneva

Head of Department

SPAIN

View details

Maria-Jesus Pinazo

Head

SWITZERLAND

View details

Sun Hee Lee

SOUTH KOREA

View details

Montserrat Laguno Centeno

Institut d'Investigacions Biomèdiques August Pi i Sunyer

SPAIN

View details

David Garcia-Hernandez

Associated Professor

Universitat Autònoma de Barcelona Facultat de Medicina

SPAIN

View details

Yolanda María Pacheco

SPAIN

View details

ESTEBAN MARTINEZ

Senior Consultant & Associate Professor of Medicine

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Josep Mallolas Masferrer

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Usability and User's Satisfaction of an Electronic Case Report Form Implemented in the REDCap System in the HIV Clinical Research Context: The Use Case of DOLAM Clinical Trial

Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort

Epidemiological changes and outcomes of people living with HIV admitted to the intensive care unit: a 14-year retrospective study

HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells

Multidrug-resistant urethritis caused by Haemophilus parainfluenzae: Susceptibility pattern and fosfomycin as an alternative treatment

Efficacy and safety of raltegravir plus lamivudine maintenance therapy.

Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV

Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis

Epidemiology, treatment and prognosis of HIV infection in 2024: A practical review,Epidemiología, tratamiento y pronóstico de la infección VIH en 2024: revisión práctica

Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.

Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre

Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4<sup>+</sup> T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy

Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City: a Cross-Sectional Study

Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study (Infectious Diseases and Therapy, (2021), 10, 3, (1253-1266), 10.1007/s40121-021-00448-0)

Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients

Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections

Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients

Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study

Collaborators (9)

Alexy Inciarte

FREDERIC GOMEZ

Yuliya Poliakova Mazneva

Maria-Jesus Pinazo

Sun Hee Lee

Montserrat Laguno Centeno

David Garcia-Hernandez

Yolanda María Pacheco

ESTEBAN MARTINEZ

Make your next move.